Glutamate is an amino acid that serves as the most abundant excitatory neurotransmitter in your brain. It’s involved in more than 90% of all excitatory signaling in the human nervous system, meaning it’s the primary chemical responsible for telling your brain cells to fire. Beyond its role in the brain, glutamate is also a building block of proteins and a naturally occurring compound in many foods.
How Glutamate Works in the Brain
Neurotransmitters are chemicals that carry signals between nerve cells. Some are excitatory, meaning they encourage the next cell to fire, and some are inhibitory, meaning they tell it to stay quiet. Glutamate is the brain’s main excitatory messenger. When a nerve impulse reaches the end of a neuron, calcium floods in, causing tiny packets of glutamate to fuse with the cell membrane and release their contents into the gap between neurons (the synapse). Glutamate then docks onto receptors on the neighboring cell, opening channels that let charged particles rush in and trigger a new electrical signal.
Your brain has several types of glutamate receptors, each with a different job. The fastest-acting ones open ion channels directly when glutamate binds to them, producing near-instant signaling. Two of the most studied are AMPA receptors, which handle routine fast communication, and NMDA receptors, which play a specialized role in learning and memory. A third type, called metabotropic receptors, works more slowly by triggering chemical cascades inside the cell rather than opening a channel directly.
Glutamate’s Role in Learning and Memory
One of the most important things glutamate does is strengthen connections between neurons, a process called long-term potentiation (LTP). This is widely considered the cellular basis of learning and memory. It works through a two-step process involving both AMPA and NMDA receptors.
During normal signaling, AMPA receptors handle the baseline conversation between neurons. NMDA receptors, however, stay blocked until the receiving neuron is already partially activated. When a signal is strong or repeated enough, the block lifts, and NMDA receptors allow calcium to enter the cell. That calcium surge triggers a chain of events that brings additional AMPA receptors to the synapse, essentially turning up the volume on that particular connection. Some synapses start out “silent,” containing only NMDA receptors, and become active only after AMPA receptors are inserted during this strengthening process. The physical structure of the synapse also changes: the connection point on the receiving neuron grows larger, scaling with the number of new receptors added.
How the Brain Recycles Glutamate
Because too much glutamate in the wrong place at the wrong time is dangerous, your brain has an efficient recycling system. After glutamate is released into the synapse and delivers its signal, nearby support cells called astrocytes absorb it through specialized transporters. Inside the astrocyte, glutamate is converted into glutamine, a closely related but inactive molecule. The astrocyte then releases glutamine back into the surrounding space, where neurons pick it up and convert it back into glutamate for reuse. This loop, called the glutamate-glutamine cycle, keeps glutamate levels tightly controlled so signaling stays precise and excess glutamate doesn’t linger where it can cause harm.
Glutamate and GABA: A Balancing Act
Glutamate has a direct chemical relationship with GABA, the brain’s most important inhibitory neurotransmitter. An enzyme called glutamate decarboxylase (GAD) converts glutamate into GABA, meaning the brain’s primary “go” signal is literally the raw material for its primary “stop” signal. This balance between excitation and inhibition is fundamental to normal brain function. When the balance tips too far toward excitation, the result can be seizures, anxiety, or cell damage. When it tips too far toward inhibition, the brain becomes sluggish.
What Happens When Glutamate Goes Wrong
When glutamate accumulates excessively in the synapse, it can overstimulate neurons to the point of injury or death, a process called excitotoxicity. The cascade begins with overactivation of NMDA receptors, which allows too much calcium to flood into the neuron. That calcium overload damages mitochondria (the cell’s energy-producing structures), generates harmful reactive oxygen species, and triggers the release of zinc inside the cell, which amplifies the damage further. The neuron’s internal environment becomes so disrupted that it can no longer function and eventually dies.
This process is implicated in several neurological conditions. In ALS (amyotrophic lateral sclerosis), motor neurons become hyperexcitable due to increased glutamate signaling. Up to 60 to 70% of patients with sporadic ALS show a 30 to 95% loss of the astrocytic transporter responsible for clearing glutamate from synapses, meaning the recycling system described above is severely impaired. Their neurons also have changes that make certain receptors more permeable to calcium, compounding the problem.
In Alzheimer’s disease, amyloid-beta protein aggregates disrupt calcium balance in neurons, leaving them more vulnerable to glutamate-driven toxicity. In animal models relevant to epilepsy, neurons with impaired glutamate receptor editing show 30 times higher calcium permeability than normal neurons, leading to seizures. All three conditions share a common thread: either too much glutamate in the synapse, receptors that are too sensitive to it, or both.
Glutamate in Food
Glutamate isn’t just a brain chemical. It’s one of the most common amino acids in food and is largely responsible for the savory taste known as umami. Parmesan cheese contains about 1,680 milligrams of glutamate per 100 grams. Soy sauce has up to 1,700 milligrams per 100 grams. Even fresh tomatoes contain around 250 milligrams per 100 grams. Monosodium glutamate (MSG), a common seasoning, is simply the sodium salt of glutamate.
A natural question is whether eating glutamate-rich foods affects your brain. The short answer is no, at least not in healthy people. The blood-brain barrier is organized specifically to prevent glutamate from entering the brain from the bloodstream. Transporters on the brain side of the barrier actively pull glutamate out of brain fluid and push it into the blood, not the other way around. This means even high dietary glutamate intake doesn’t raise brain glutamate levels. The only exceptions are a few tiny regions of the brain where the barrier has natural gaps, but these are small and serve specialized sensing functions.
Medications That Target Glutamate
Because glutamate is so central to brain function and disease, it has become an important drug target. Several approved medications work by modulating the glutamate system. Memantine, used in moderate to severe Alzheimer’s disease, partially blocks NMDA receptors to reduce the excitotoxic damage caused by chronic glutamate overactivity. Riluzole, the first drug approved for ALS, works in part by reducing glutamate release. In 2025, esketamine (a nasal spray that blocks NMDA receptors) was approved as a standalone treatment for treatment-resistant depression, reflecting growing recognition that glutamate signaling plays a role in mood disorders, not just neurodegenerative diseases.